Prostate Cancer
2nd Edition
Published on 30. October 2000
Book
Hardback
256 pages
978-0-7234-3167-1 (ISBN)
Description
"Prostate Cancer (2E)" covers the most recent advances in this important and fast-moving area. The book is a concise and practical text, enhanced with specially commissioned computer graphics and full colour illustrations. It presents a comprehensive account of all the important issues affecting the investigation, diagnosis and management of this disease, including molecular mechanisms, tumour markers, pathology, and screening. There is a wealth of information on new therapies, and the very latest information on drug treatment. This was a highly commended title at the 2001 BMA Medical Book Awards.
More details
Edition
2nd Revised edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
Professional and scholarly
Urologists
General practitioners
A minor cross-over market with oncologists and radiotherapists (the vast majority of prostate care continues to be managed by urologists)
General practitioners
A minor cross-over market with oncologists and radiotherapists (the vast majority of prostate care continues to be managed by urologists)
Edition type
Revised edition
Illustrations
250 ills.
Dimensions
Height: 216 mm
Width: 140 mm
Weight
930 gr
ISBN-13
978-0-7234-3167-1 (9780723431671)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
Previous edition
Roger S. Kirby | Timothy J. Christmas | Michael K. Brawer
Prostate Cancer
Book
08/1995
Mosby
€121.81
Article exhausted; check for reprint
Persons
Content
Preface. The problem. Anatomical and pathological considerations. Epidemiological aspects. Molecular basis of prostate cancer. Clinical.presentation. Tumor markers in prostate cancer. Early diagnosis and screening for prostate cancer. Imaging and staging of prostate cancer. Treatment of localized prostate cancer. Alternative strategies for localized prostate cancer. Locally advanced prostate cancer. Management of metastatic disease. Management of hormone escaped prostate cancer. Brachytherapy. Sexual function and prostate cancer. The future: reasons to be cheerful. Appendix.